These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22687730)

  • 1. [Identification of a molecular mechanism for actions of existing medicines and its application for drug development].
    Mizushima T
    Yakugaku Zasshi; 2012; 132(6):713-20. PubMed ID: 22687730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug discovery and development focusing on existing medicines: drug re-profiling strategy.
    Mizushima T
    J Biochem; 2011 May; 149(5):499-505. PubMed ID: 21436140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organic chemistry in drug discovery.
    MacCoss M; Baillie TA
    Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities and challenges in the discovery of new central nervous system drugs.
    Krause JE; Chenard BL
    Ann N Y Acad Sci; 2008 Nov; 1144():243-50. PubMed ID: 19076381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches for high-throughput pharmacokinetic screening of low-molecular-weight drug candidates.
    Fontana S
    Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):139-42. PubMed ID: 24329157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De-risking drug discovery with ADDME -- avoiding drug development mistakes early.
    Tsaioun K; Jacewicz M
    Altern Lab Anim; 2009 Sep; 37 Suppl 1():47-55. PubMed ID: 19807206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do the top 12 pharmaceutical companies operate safety pharmacology?
    Ewart L; Gallacher DJ; Gintant G; Guillon JM; Leishman D; Levesque P; McMahon N; Mylecraine L; Sanders M; Suter W; Wallis R; Valentin JP
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):66-70. PubMed ID: 22510338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current trends in epigenetic drug discovery.
    Stolfa DA; Einsle O; Sippl W; Jung M
    Future Med Chem; 2012 Oct; 4(16):2029-37. PubMed ID: 23157236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemistry strategies in early drug discovery: an overview of recent trends.
    Colombo M; Peretto I
    Drug Discov Today; 2008 Aug; 13(15-16):677-84. PubMed ID: 18675762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolite identification and profiling in drug design: current practice and future directions.
    Zhang Z; Zhu M; Tang W
    Curr Pharm Des; 2009; 15(19):2220-35. PubMed ID: 19601824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Driving drug discovery: the fundamental role of academic labs.
    Silber BM
    Sci Transl Med; 2010 May; 2(30):30cm16. PubMed ID: 20445199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homochiral drugs: a demanding tendency of the pharmaceutical industry.
    Núñez MC; García-Rubiño ME; Conejo-García A; Cruz-López O; Kimatrai M; Gallo MA; Espinosa A; Campos JM
    Curr Med Chem; 2009; 16(16):2064-74. PubMed ID: 19519381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A framework to assess the translation of safety pharmacology data to humans.
    Valentin JP; Bialecki R; Ewart L; Hammond T; Leishmann D; Lindgren S; Martinez V; Pollard C; Redfern W; Wallis R
    J Pharmacol Toxicol Methods; 2009; 60(2):152-8. PubMed ID: 19616110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery: a historical perspective.
    Drews J
    Science; 2000 Mar; 287(5460):1960-4. PubMed ID: 10720314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a best strategy for drug discovery?
    Warne P; Page C
    Drug News Perspect; 2003 Apr; 16(3):177-82. PubMed ID: 12819816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosensor profiling of molecular interactions in pharmacology.
    Cooper MA
    Curr Opin Pharmacol; 2003 Oct; 3(5):557-62. PubMed ID: 14559103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical research perspective.
    Tang W; Lu AY
    Drug Metab Rev; 2010 May; 42(2):225-49. PubMed ID: 19939207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.